Canaccord Genuity Reiterates a 'Buy' on Cadence Pharma (CADX); Expect Growing Ofirmev Adoption
Get Alerts CADX Hot Sheet
Price: $13.98 --0%
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Cadence Pharma (NASDAQ: CADX) price target of $9.00.
Analyst, Ritu Baral, said, "Reiterate rating and price target on Ofirmev’s ultimate commercial potential driven by outpatient use. We think Ofirmev will ultimately be used in post-op analgesia in ~1/3 of US surgical procedures with peak US sales of $643M. We think Ofirmev will see the most use in outpatient surgery and ambulatory care...We expect additional targeted marketing campaign to drive surgeon pull-through, higher vial per patient use and Ofirmev revenue."
For an analyst ratings summary and ratings history on Cadence Pharma click here. For more ratings news on Cadence Pharma click here.
Shares of Cadence Pharma closed at $3.79 yesterday.
Analyst, Ritu Baral, said, "Reiterate rating and price target on Ofirmev’s ultimate commercial potential driven by outpatient use. We think Ofirmev will ultimately be used in post-op analgesia in ~1/3 of US surgical procedures with peak US sales of $643M. We think Ofirmev will see the most use in outpatient surgery and ambulatory care...We expect additional targeted marketing campaign to drive surgeon pull-through, higher vial per patient use and Ofirmev revenue."
For an analyst ratings summary and ratings history on Cadence Pharma click here. For more ratings news on Cadence Pharma click here.
Shares of Cadence Pharma closed at $3.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- Cummins (CMI) PT Lowered to $675 at Jefferies
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share